Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands.
作者:
主题词
细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);减量调节(Down-Regulation);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);凋亡抑制蛋白质类(Inhibitor of Apoptosis Proteins);K562细胞(K562 Cells);配体(Ligands);磷酰化(Phosphorylation);蛋白质结合(Protein Binding);蛋白激酶抑制剂(Protein Kinase Inhibitors);噻唑类(Thiazoles);泛素化(Ubiquitination)
DOI
10.1111/cas.13284
PMID
28556300
发布时间
2021-12-04
- 浏览17

Cancer science
1657-1666页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文